Analysis of cartilage-specific IDH mutant mice for explication of underlying mechanism in chondrosarcoma development
Project/Area Number |
15K18398
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor biology
|
Research Institution | The University of Tokyo |
Principal Investigator |
Hirata Makoto 東京大学, 医科学研究所, 特任助教 (50401071)
|
Research Collaborator |
Alman Benjamin A.
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 軟骨腫瘍 / イソクエン酸デヒドロゲナーゼ / 腫瘍 / 軟骨 / 代謝 |
Outline of Final Research Achievements |
Central chondrosarcomas are known to harbor frequent mutation in IDH1 or IDH2 genes. The objective of the current study is to generate genetically-engineered mice expressing mutant IDH1 or IDH2 specifically in cartilage and to elucidate the underlying mechanism of chondrosarcoma occurrence and development. The mutant IDH1 or IDH2 mice exhibited dwarfism as compared to their wild-type littermate, with morphologically abnormal growth plate cartilage. Of note, the IDH2 mutant mice harbored severer phenotype in cartilage than the IDH1 mutant mice. The mutant IDH1 or IDH2 mice with p53 deficiency were generated by crossing with p53-flox mice. No clear evidence of bone tumor development has been observed until the age of three months old.
|
Report
(3 results)
Research Products
(10 results)
-
-
[Journal Article] Biphasic regulation of chondrocytes by Rela through induction of anti-apoptotic and catabolic target genes.2016
Author(s)
Kobayashi H, Chang S, Mori D, Itoh S, Hirata M, Hosaka Y, Taniguchi Y, Okada K, Mori Y, Yano F, Chung U, Akiyama H, Kawaguchi H, Tanaka S, Saito T.
-
Journal Title
Nat Commun
Volume: 7
Issue: 1
Pages: 13336-13336
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.2016
Author(s)
Sato S, Tang YJ, Wei Q, Hirata M, Weng A, Han I, Okawa A, Takeda S, Whetstone H, Nadesan P, Kirsch DG, Wunder JS, Alman BA.
-
Journal Title
Cell Rep.
Volume: 16
Issue: 4
Pages: 917-27
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma.2015
Author(s)
Wei Q, Tang YJ, Voisin V, Sato S, Hirata M, Whetstone H, Han I, Ailles L, Bader GD, Wunder J, Alman BA.
-
Journal Title
Oncotarget
Volume: 6
Issue: 37
Pages: 40283-94
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-